Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04734483
Other study ID # Aliya_Turayeva
Secondary ID dr.turayeva
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date June 1, 2021

Study information

Verified date January 2021
Source Astana Medical University
Contact Aliya Turayeva, PhD
Phone +77073681054
Email cvetalnur@mail.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To improve diagnostic methods for patients with laryngeal stenosis for the optimal determination of the technique of surgical treatment.


Description:

The study include patients with laryngeal pathology in the otorhinolaryngology clinic of the 1-city hospital at Nur-Sultan city. All patients cheek up the necessary clinical, functional, diagnostic studies and treatment measures. It is planned to examine and operate on 70 patients with laryngeal pathology. 1. To study the features of the course of stenosis of the larynx under the influence of various factors, as well as traumatic injuries. 2. To develop optimal diagnostic methods for patients with laryngeal stenosis. 3. To assess the effectiveness of endolaryngeal microsurgery in patients with laryngeal stenosis. 4. To develop recommendations for the organization of treatment for stenosis of the larynx with an increase its functional state.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date June 1, 2021
Est. primary completion date May 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 74 Years
Eligibility Inclusion Criteria: - medically diagnosed with stenosis of larynx - patients who were observed larynx by MRI and CT - patients who need surgical treatment of stenosis of larynx Exclusion Criteria: - pregnancy - patients who has positive electromyography findings of motion of laryngeal muscles - patients who has contraindications to surgical treatment on the other diseases - patients who has not normal results of lab. analyses

Study Design


Intervention

Diagnostic Test:
spirometry
spirometry
Radiation:
MRI and CT
MRI and CT
Other:
Laryngoscopy
laryngoscopy
electromyography
electromyography

Locations

Country Name City State
Kazakhstan Astana Medical University Astana
Russian Federation Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech Saint Petersburg

Sponsors (1)

Lead Sponsor Collaborator
Astana Medical University

Countries where clinical trial is conducted

Kazakhstan,  Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline forced expiratory volume Spirometry at baseline and at 24-week postrandomization
Primary Change from baseline area between vocal cords MRI and CT of larynx at baseline and at 24-week postrandomization
Primary Change from basiline vocal fold vibration Laryngoscopy and stroboscopy at baseline and at 24-week postrandomization
Primary Evaluate the motor system by recording action potential generated in muscle fibres like thyroarytenoid, lateral cricoarytenoid, posterior cricoarytenoid, interarytenoid, cricothyroid. Electromyography at baseline
See also
  Status Clinical Trial Phase
Completed NCT00373997 - Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Phase 4
Completed NCT00372918 - Interpretation of Transnasal Esophagoscopy Findings Phase 4
Completed NCT00388453 - Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease Phase 3
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Completed NCT00444145 - Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? Phase 4
Completed NCT01360580 - Swallowing Disorders After Prolonged Mechanical Ventilation N/A
Withdrawn NCT00567658 - Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas Phase 3
Completed NCT00335283 - Efficacy of Lansoprazole in Chronic Post Nasal Drip Phase 3
Completed NCT03843580 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo) N/A